Episode 499: APCCC 2026 - Radioligands in Prostate Cancer

from The Uromigos · host The Uromigos

This session features expert Michael Morris discussing radioligand therapy, adaptive dosing, retreatment strategies, and the latest insights in prostate cancer treatment. Gain a deep understanding of current practices, challenges, and future directions in radiopharmaceuticals.

Episode metadata supplied by the publisher feed · Published May 25, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 499: APCCC 2026 - Radioligands in Prostate Cancer

0:00 37:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Uromigos?

This episode is 37 minutes long.

When was this The Uromigos episode published?

This episode was published on May 25, 2026.

Can I download this The Uromigos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!